Across Africa, access to safe, effective, and quality-assured medicines is shaped as much by regulatory systems as it is by scientific innovation. While many countries have made significant progress in strengthening their National Regulatory Authorities (NRAs), uneven capacity, fragmented requirements, and duplicated assessments continue to slow patient access to essential health products. Regulatory reliance offers a practical path forward.
At its core, regulatory reliance is a trust-based approach that allows one regulatory authority to consider and use the work products, decisions, or scientific assessments of another trusted authority when making its own regulatory decisions. Rather than each country repeating the same evaluations independently, reliance promotes collaboration, information sharing, and more efficient use of limited regulatory resources.
For Africa, the potential of this approach is considerable. Differences in population genetics, disease patterns, and environmental factors may sometimes require localised evaluation of medicines and health technologies. However, most African NRAs simply do not have the capacity to duplicate technical assessments that have already been rigorously conducted by trusted regulators.
The recently advanced Continental Reliance Framework reflects growing recognition that stronger cooperation between NRAs is essential for improving access to medicines, supporting local manufacturing, and strengthening regulatory maturity across the continent.
Reducing duplication and regulatory burden
One of the most immediate benefits of regulatory reliance is the reduction of duplicated effort. Many African regulators are required to assess the same dossiers independently, often with limited staff and technical capacity. This places pressure on regulatory systems and creates inefficiencies for manufacturers who must navigate multiple, sometimes divergent, regulatory requirements.
By leveraging assessments conducted by trusted authorities or regional partners, regulators can focus their expertise where it is most needed. This allows scarce resources to be redirected toward post-market surveillance, pharmacovigilance, inspections, and enforcement activities that directly protect public health.
For manufacturers, reliance pathways can create a more predictable and efficient regulatory environment. Clear processes reduce administrative burden, shorten time to market, and make African markets more attractive for investment, including local production.
When reliance meets real-world complexity
While regulatory reliance is widely recognised as a mechanism to improve efficiency, its practical implementation can be more complex.
South African Health Products Regulatory Authority (SAHPRA) provides a useful illustration. The authority has introduced reliance pathways that allow regulatory decisions to draw on assessments conducted by recognised regulators such as the European Medicines Agency, the U.S. Food and Drug Administration, and the World Health Organization Prequalification Programme. SAHPRA also participates in regional reliance initiatives such as ZAZIBONA and continental mechanisms linked to the African Medicines Agency.
In principle, these pathways allow applicants to submit dossiers that have already been assessed by trusted authorities, enabling abridged reviews rather than full independent evaluations.
In practice, however, reliance submissions are sometimes rejected or redirected to full review. One commonly cited challenge is the requirement for unredacted assessment reports from reference regulators, which applicants may not always be able to access due to confidentiality restrictions. In other cases, submissions fail because the local dossier does not perfectly align with the reference approval, including differences in product information, indications, or manufacturing specifications.
These challenges highlight an important lesson: the existence of reliance frameworks alone does not guarantee alignment between regulators and industry. Effective reliance requires clear documentation requirements, practical guidance, and strong communication between applicants and authorities.
Accelerating access to quality medicines
When reliance systems function effectively, they can directly improve patient access. By leveraging trusted scientific assessments, regulators can shorten approval timelines without compromising safety, quality, or efficacy.
This is particularly important for priority medicines, vaccines, and treatments addressing diseases with a high burden across the continent. Reliance mechanisms can also support faster regulatory responses during public health emergencies by enabling authorities to make informed decisions based on existing scientific evaluations.
Importantly, reliance is not about lowering standards. It is about applying scientific evidence more efficiently and avoiding unnecessary duplication of work that has already been conducted by credible authorities.
Building regulatory maturity through collaboration
Beyond efficiency, reliance contributes to long-term regulatory capacity building. Participation in reliance frameworks exposes NRAs to structured assessment methodologies, international best practices, and quality management systems.
Over time, this promotes regulatory learning, skills development, and institutional strengthening. Authorities participating in reliance processes also contribute local expertise and contextual insights, reinforcing a cycle of mutual trust and shared development.
These collaborative models align closely with Africa’s broader regulatory ambitions, including the work of the African Medicines Agency and regional harmonisation initiatives. Reliance can provide a practical foundation for harmonisation by encouraging convergence in standards, processes, and regulatory expectations while respecting national contexts.
What this means for Africa’s health future
Regulatory reliance represents a shift away from isolated decision-making toward a more connected and resilient regulatory ecosystem. For Africa, this approach supports faster access to medicines, stronger regulatory systems, and greater confidence for manufacturers and investors.
It also reinforces a broader vision of health sovereignty. By working together, African regulators can reduce duplication, strengthen internal capacity, and create a regulatory environment that supports innovation and local manufacturing.
At Vicore Health, we see regulatory reliance as a cornerstone of smarter regulation in Africa. By supporting trust-based collaboration, strengthening regulatory systems, and aligning practices across jurisdictions, reliance offers a practical pathway toward improved health outcomes and more resilient healthcare systems across the continent.